There is a whole lot of movement going on in this little NZ based stock.
PEB has made dramatic gains in the last two days following recent announcements which show that it has made significant steps into the lucrative US medical market with its special test for the early detection of bladder cancer.
At one stage till about September 2012 it hovered around the 20 cent level then began creeping up to about mid 40 cents by late December.
It got over 50 cent early in January this year and fluctuated between 50 and mid 60's for several months. Just under 2 weeks ago it was at the 50 cent level but then began to climb as a series of announcements began to flow.
It jumped up to over 70 cents and then yesterday climbed to over a dollar. That soaring continued this morning with it hitting a high of $1.75 before slowly easing back.
Yet income flow is just at an initial stage but the future prospects appear very bright for this biotech company with a significant cancer test.
Add to My Watchlist
What is My Watchlist?
